Literature DB >> 29761499

Isobornyl acrylate contained in the insulin patch pump OmniPod as the cause of severe allergic contact dermatitis.

Eva Oppel1, Christof Högg2,3, Burkhard Summer1, Franziska Ruëff1, Franz-Xaver Reichl2,3, Stefanie Kamann4.   

Abstract

Entities:  

Keywords:  Freestyle Libre; OmniPod; acrylates; allergic contact dermatitis; case report; insulin patch pump; isobornyl acrylate; patch test

Mesh：

Substances：

Year:  2018        PMID： 29761499     DOI： 10.1111/cod.13017

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN： 0105-1873            Impact factor:   6.600


× No keyword cloud information.
  5 in total

1.  Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.

Authors:  Rachel S Rigo; Laura E Levin; Donald V Belsito; Maria C Garzon; Rachelle Gandica; Kristen M Williams
Journal:  J Diabetes Sci Technol       Date:  2020-05-09

2.  High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey.

Authors:  Fortunato Lombardo; Stefano Passanisi; Davide Tinti; Maria Francesca Messina; Giuseppina Salzano; Ivana Rabbone
Journal:  J Diabetes Sci Technol       Date:  2020-08-06

Review 3.  [Contact allergy due to insulin pumps and glucose sensor systems].

Authors:  N Wagner; S Kamann; E Oppel
Journal:  Hautarzt       Date:  2020-03       Impact factor: 0.751

Review 4.  Contact Allergy-Emerging Allergens and Public Health Impact.

Authors:  Wolfgang Uter; Thomas Werfel; Jean-Pierre Lepoittevin; Ian R White
Journal:  Int J Environ Res Public Health       Date:  2020-04-01       Impact factor: 3.390

5.  Technologies for Type 1 Diabetes and Contact Dermatitis: Therapeutic Tools and Clinical Outcomes in a Cohort of Pediatric Patients.

Authors:  Stefano Passanisi; Giuseppina Salzano; Francesca Galletta; Sara Aramnejad; Lucia Caminiti; Giovanni B Pajno; Fortunato Lombardo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-15       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.